Health Care: Drugs

Albany Molecular Research Inc (AMRI: NASDAQ)

$18.6 -0.44 | -2.31%
08/01/14 - 11:00 AM ET
Company Profile
Price and Volume
Recent Price 19.04
52 Week High 22.30
52 Week Low 9.71
Avg. Daily Vol. (Mil) 0.44
Beta (3 year) 2.09
Share Related Items
Mkt Cap (Mil) 616.21
Shares Out (Mil) 32.36
Float (Mil) 23.93
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.00
Current Ratio 7.20
LT Debt/ Equity 0.49
Total Debt / Equity 0.50
Valuation Ratios
Price Earnings 61.40
Price/Sales 2.50
Price/Book 2.44
Price/Cash Flow 22.50
Per Share Data
Earnings 0.31
Sales 7.62
Book Value 7.80
Cash Flow 0.85
Business Summary
Albany Molecular Research Inc is a contract research and manufacturing organization providing customers drug discovery, development and manufacturing services.
General Information
26 Corporate Circle
Albany, NY 12203
www.amriglobal.com
Industry : Drugs
Sector: Health Care
Employees: 1282
CEO: William S. Marth
Short Interest
Current Month (Mil) 7.10
Previous Month (Mil) 6.44
Short Interest Ratio (Days) 11.90
Management Effectiveness
Return on Equity 3.80
Return on Assets 1.90
Return on Investments 2.60
Profitability
Gross Margin 35.90
EBIT Margin 7.50
Profit Margin 3.90

Portfolios with AMRI

Latest AMRI Headlines from TheStreet

More Financial News for AMRI

Press Releases for AMRI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter